Journal of Clinical Medicine Research

This paper aims to discuss the K1C2 Oligopeptide Four-Source Factor, a multi-targeted enzyme complex for the treatment of metabolic syndrome due to its effects on the specific enzymes. Metabolic syndrome is a cluster of conditions that are related by shared risk factors and considerably increase the chances of developing cardiovascular disease and type 2 diabetes. The K1C2 complex contains subgroups of KE-1 oligopeptide enzymes and CE-2 oligopeptide SOD complexes which act on glycolytic enzymes, lipoprotein lipase, ACE inhibitors and antioxidant systems. The component analysis is done to find out that the interaction between clam-derived ACE inhibitory peptides, oat β-glucan complexes, HIBIO plant enzymes and SOD/broccoli pollen extracts is synergistic. Clinical studies comparing the effectiveness of this supplemsent to other single-enzyme supplements such as nattokinase or hirudin also show improved results. Sophisticated preservation technique ensures that the enzymatic activity is fully preserved throughout the entire metabolic processes. Such an approach in the context of the enzymatically based metabolic deficiency is revolutionary for the strategy of the metabolic syndrome correction as it allows for the multiple-angle regulation of the sugar, lipid, pressure, and oxidative stress levels using the enzyme-targeting approach.